...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Gasoline

At the AGM the longest dosed patient on ZEN3964 was just over 4 months. If we are still going it speaks volumes for our potential.

tada

Share
New Message
Please login to post a reply